Takeda
TOKYO: Takeda Pharmaceutical Co is planning what would be the biggest single tranche Japanese corporate yen bond sale in an effort to extend its debt obligations following its US$62bil purchase of Shire Plc, according to people with knowledge of the discussions.
The drug maker is planning to sell as much as 500 billion yen (US$4.6bil) of hybrid notes in the fiscal year starting April 1, said the people, who asked not to be identified because the details are private.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
